21 May 2013
Keywords: gsk, licenses, otc, orlistat, roche, companies, settle
Article | 26 February 2007
GlaxoSmithKline has acquired the exclusive rights to the weight-loss medicine, orlistat, from Swiss drug major Roche, for over-the-counter
sale in ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 February 2007
20 May 2013
© 2013 thepharmaletter.com